Cargando…
A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention
Optimal antiplatelet therapy after endovascular therapy (EVT) for peripheral artery disease is controversial. This trial aimed to evaluate whether sarpogrelate plus aspirin was non-inferior for preventing early restenosis after femoropopliteal (FP) EVT compared to clopidogrel plus aspirin. In this o...
Autores principales: | Han, Ahram, Lee, Taeseung, Lee, Joongyub, Song, Suk-Won, Lee, Sang-Su, Jung, In Mok, Kang, Jin Mo, Gwon, Jun Gyo, Yun, Woo-Sung, Cho, Yong-Pil, Ko, Hyunmin, Park, Yang-Jin, Min, Seung-Kee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925771/ https://www.ncbi.nlm.nih.gov/pubmed/36781928 http://dx.doi.org/10.1038/s41598-023-29006-z |
Ejemplares similares
-
Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results
por: Chen, Yue-Xin, et al.
Publicado: (2015) -
Rivaroxaban after Thrombolysis in Acute Iliofemoral Venous Thrombosis: A Randomized, Open-labeled, Multicenter Trial
por: Kang, Jin Mo, et al.
Publicado: (2019) -
SAFE (Sarpogrelate Anplone in Femoro-popliteal artery intervention Efficacy) study: study protocol for a randomized controlled trial
por: Ahn, Sanghyun, et al.
Publicado: (2017) -
Aspirination of α-Aminoalcohol (Sarpogrelate M1)
por: Park, Sunhwa, et al.
Publicado: (2016) -
Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim Database
por: Noh, Yoojin, et al.
Publicado: (2016)